Ocwen Financial (OCN) Misses Q1 EPS by 9c, Beats on Revenues

Compass Point Downgrades Ocwen Financial Corp (OCN) to Neutral

Compass Point downgraded Ocwen Financial Corp (NYSE: OCN) from Buy to Neutral.

For an analyst ratings summary and ratings history on Ocwen Financial Corp click here. For more ratings news on Ocwen Financial Corp click here.

Shares of Ocwen Financial Corp closed at $3.10 yesterday.

New Residential Investment's (NRZ) MSR Deal with Ocwen Financial (OCN) Seen as 'Savvy Move' at FBR

FBR Capital maintained an Outperform rating on New Residential Investment (NYSE: NRZ) with a price target of $17.50. Comments follow earnings and its agreement with Ocwen Financial (NYSE: OCN) to purchase $117 billion of MSRs on which it owns the excess servicing for $425 million. Analyst Jessica Levi-Ribner said MSR economics look accretive and called the deal a "savvy move."

"NRZ currently... More

UPDATE: Piper Jaffray Upgrades Ocwen Financial Corp (OCN) to Neutral

(Updated - May 1, 2017 2:10 PM EDT)

(updated to add analyst comment)

Piper Jaffray upgraded Ocwen Financial Corp (NYSE: OCN) from Underweight to Neutral, a price target of $3.50 (from $2.00) which he says reflects $2.74 gain on NRZ transaction.

Analyst Kevin Barker cites... More

Ocwen Financial (OCN) Resumes Trading

Ocwen Financial (NYSE: OCN) Resumes Trading

Ocwen Financial (OCN) Confirms Working Toward Agreement with New Residential (NRZ)

Ocwen Financial Corporation, (NYSE: OCN) today announced it is working with New Residential Corporation (NYSE: NTZ) towards an agreement that would further solidify and enhance the business relationship between the two companies. The proposed new agreement relates to approximately $117 billion... More

New Residential Investment's (NRZ) $425M MSR Deal with Ocwen Financial (OCN) Seen as Positive at KBW

Keefe, Bruyette & Woods analyst Bose George said he expects a generally positive impact in New Residential Investment (NYSE: NRZ) following its Q1 beat and comments related to its $425 million deal to purchase MSRs from Ocwen (NYSE:... More